Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Analysis of Long-term (Investment) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Dividend Discount Model (DDM)
- Return on Equity (ROE) since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Income statement item | Description | The company |
---|---|---|
Revenues | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | Vertex Pharmaceuticals Inc. revenues increased from 2021 to 2022 and from 2022 to 2023. |
Income from operations | The net result for the period of deducting operating expenses from operating revenues. | Vertex Pharmaceuticals Inc. income from operations increased from 2021 to 2022 but then slightly decreased from 2022 to 2023. |
Income before provision for income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Vertex Pharmaceuticals Inc. income before provision for income taxes increased from 2021 to 2022 and from 2022 to 2023. |
Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Vertex Pharmaceuticals Inc. net income increased from 2021 to 2022 and from 2022 to 2023. |